Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Boyett

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Lipid Research|May 1, 1978
The picomole determination of free and total cholesterol in cells in cultureJ G Heider, R L Boyett
Academic Medicine : Journal of the Association of American Medical Colleges|October 1, 1994
Standardized patients and licensing examinationsR C Worthington, S E Willis, R L Boyett
Clinical Pharmacology and Therapeutics|November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kineticsJ L Borges, H F Schran, W S Evans, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study GroupW H Utian, K A Burry, D F Archer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Lipid Research|May 1, 1978
The picomole determination of free and total cholesterol in cells in cultureJ G Heider, R L Boyett
Academic Medicine : Journal of the Association of American Medical Colleges|October 1, 1994
Standardized patients and licensing examinationsR C Worthington, S E Willis, R L Boyett
Clinical Pharmacology and Therapeutics|November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kineticsJ L Borges, H F Schran, W S Evans, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study GroupW H Utian, K A Burry, D F Archer, et al.
Pageof 1